Evidence generation in medical affairs

Evidence generation, a case for change in value demonstration and a key to unlock the future of the medical affairs organization.

Medical lab

Authors: 
Silvia Ondategui-Parra, Ginni Wadhwa, Maria Iglesias, Emily Flochel 

Publication: 
April 2023

Language: 
English

Number of pages: 
20

Document type: 
Whitepaper

Key questions we will explore: 

  1. Explore the case for Evidence Generation and Real World Evidence (RWE) in pharmaceutical organizations
  2. Highlight how the role of the Medical affairs function should evolve towards a strategic evidence hub
  3. Understand how to best increase the value of the evidence generated , through an Integrated Evidence plan prepared with cross-collaboration within the organization.

Please fill in the form below to receive the whitepaper:

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Limited, each of which is a separate legal entity. Ernst & Young Limited is a Swiss company with registered seats in Switzerland providing services to clients in Switzerland.